Brookdale Senior Living Inc. (BKD) Stock Forecast
Data as of May 2, 2026Healthcare · Current price $14.39 (+0.24%)
Price Target Range
Consensus Price Target Over Time
Analyst Rating Distribution
Last 3 Months
6-Month Trend
Latest Analyst Forecasts
Price targets issued by Wall Street analysts. Upside calculated against today's price.
| Date | Analyst | Firm | Price Target | Upside |
|---|---|---|---|---|
| Jan 22, 2026 | Andrew Mok | Barclays | $15.00 | +4.2% |
| Nov 10, 2025 | Andrew Mok | Barclays | $14.00 | -2.7% |
| Aug 7, 2025 | Andrew Mok | Barclays | $8.00 | -44.4% |
| Apr 1, 2025 | Andrew Mok | Barclays | $7.00 | -51.4% |
| Oct 16, 2024 | Brian Tanquilut | Jefferies | $8.00 | -44.4% |
| Jul 12, 2023 | Ben Hendrix | RBC Capital | $7.00 | -51.4% |
Top Analysts Covering BKD
BKD vs Sector & Market
| Metric | BKD | Healthcare Avg | Large Cap Avg |
|---|---|---|---|
| Analyst Rating | 2.14 | 2.24 | 2.41 |
| Analyst Count | 7 | 8 | 18 |
| Target Upside | +22.8% | +1150.2% | +14.9% |
| P/E Ratio | -12.61 | 6.88 | 31.19 |
Revenue Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-06-30 | $742M | $752M | $766M | 3 |
| 2026-09-30 | $737M | $747M | $761M | 1 |
| 2026-12-31 | $3.00B | $3.01B | $3.01B | 3 |
| 2027-03-31 | $762M | $775M | $782M | 3 |
| 2027-06-30 | $762M | $775M | $782M | 2 |
| 2027-09-30 | $769M | $782M | $789M | 2 |
| 2027-12-31 | $766M | $779M | $786M | 3 |
| 2028-03-31 | $805M | $818M | $826M | 2 |
| 2028-06-30 | $800M | $813M | $821M | 1 |
| 2028-09-30 | $808M | $821M | $829M | 1 |
| 2028-12-31 | $804M | $818M | $825M | 2 |
EPS Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-06-30 | $-0.07 | $-0.06 | $-0.04 | 2 |
| 2026-09-30 | $-0.06 | $-0.06 | $-0.06 | 1 |
| 2026-12-31 | $-0.21 | $-0.21 | $-0.21 | 2 |
| 2027-03-31 | $0.06 | $0.06 | $0.06 | 1 |
| 2027-06-30 | $0.02 | $0.02 | $0.02 | 1 |
| 2027-09-30 | $0.00 | $0.00 | $0.00 | 1 |
| 2027-12-31 | $0.00 | $0.00 | $0.00 | 1 |
| 2028-03-31 | $0.00 | $0.00 | $0.00 | 0 |
| 2028-06-30 | $0.00 | $0.00 | $0.00 | 0 |
| 2028-09-30 | $0.00 | $0.00 | $0.00 | 0 |
| 2028-12-31 | $0.00 | $0.00 | $0.00 | 0 |
Frequently Asked Questions
What is the analyst consensus for BKD?
The consensus among 7 analysts covering Brookdale Senior Living Inc. (BKD) is Buy with an average price target of $17.67.
What is the highest price target for BKD?
The highest price target for BKD is $15.00, set by Andrew Mok at Barclays on 2026-01-22.
What is the lowest price target for BKD?
The lowest price target for BKD is $7.00, set by Ben Hendrix at RBC Capital on 2023-07-12.
How many analysts cover BKD?
7 analysts have issued ratings for Brookdale Senior Living Inc. in the past 12 months.
Is BKD a buy or sell right now?
Based on 7 analyst ratings, BKD has a consensus rating of Buy (2.14/5) with a +22.8% upside to the consensus target of $17.67.
What are the earnings estimates for BKD?
Analysts estimate BKD will report EPS of $-0.06 for the period ending 2026-06-30, with revenue estimated at $752M.
Related Stock Forecasts
Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.